Celldex Therapeutics (CLDX) Prepaid Assets (2010 - 2026)

Celldex Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $7.5 million for Q1 2026.

• On a quarterly basis, Prepaid Assets fell 61.17% year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 61.17% decrease from a year earlier, with the FY2025 full-year figure at $14.1 million, down 33.53% from the prior year.
• Prepaid Assets retreated to $7.5 million in Q1 2026 per CLDX's latest filing, from $14.1 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $22.0 million in Q3 2024 and bottomed at $5.5 million in Q4 2023.
• The 5-year median for Prepaid Assets is $11.1 million (2022), against an average of $13.1 million.
• Across the five-year window, Prepaid Assets jumped 412.78% in 2022 and tumbled 61.17% in 2026, its largest moves.
• Year by year, Prepaid Assets stood at $12.4 million in 2022, then plunged by 55.89% to $5.5 million in 2023, then surged by 287.38% to $21.2 million in 2024, then sank by 33.53% to $14.1 million in 2025, then tumbled by 46.48% to $7.5 million in 2026.
• Per Business Quant, the three latest CLDX Prepaid Assets figures stand at $7.5 million (Q1 2026), $14.1 million (Q4 2025), and $21.0 million (Q3 2025).